Melbourne, Australia – 25 February 2022: Adherium Limited (“Adherium” or “the Company”; ASX: ADR), a provider of integrated digital health solutions and a world leader in connected respiratory medical devices, announces the appointment of Mr Lou Panaccio as a Non-executive director of Adherium with Mr Matthew McNamara stepping down as a Non-executive Director.
James Ward-Lilley, Chairman of Adherium commented “I am very pleased to welcome Lou to the Adherium Board. He brings more than 30 years of leadership experience in healthcare services, ASX and NASDAQ listings, and has extensive global commercial experience including in the United States.
The Board and I would also like to thank Matt for his contribution as an Adherium director. Matt has been a strong supporter of Adherium having been a Non-executive Director of the Company prior to its ASX listing and subsequently rejoining the Board in October 2019. Matt has brought his financial and business experience to Board as the business restructured and re-established its strategy and has been an active member of both the Audit & Risk and Nomination & Remuneration Committees”.